Abstract:Five oxovanadium(IV) complexes, which were divided into two groups, [(VO)-O-IV(bhbb, nhbb)(H2O)(2)] (tridentate ligands: H(2)bhbb = 2-(5-bromo-2-hydroxylbenzylideneamino) benzoic acid, 1; H(2)nhbb = 2-(5-nitro-2-hydroxylbenzylideneamino) benzoic acid, 2) and [(VO)-O-IV(cpmp, bpmp, npmp)(2)] (bidentate ligands: Hcpmp = 4-chloro-2-((phenylimino) methyl) phenol, 3; Hbpmp = 4-bromo-2-((phenylimino) methyl)phenol, 4; Hnpmp = 4-nitro-2-((phenylimino) methyl) phenol, 5) have been prepared and characterized by elemental analysis, infrared, UV-visible and electrospray ionization mass spectrometry. The coordination in [(VO)-O-IV(bhbb)(H2O)(2)] (1) was confirmed by X-ray crystal structure analysis. The oxidation state of V(IV) with d(1) configuration in 1-5 was confirmed by EPR. The speciation of VO/H(2)bhbb in methanol-aqueous solution was investigated by potentiometric pH titrations. The result indicated that the main species were [(VO)-O-IV(bhbb)(OH)](-) and [(VO)-O-IV(bhbb)(OH)(2)](2-) at the pH range 7.0-7.4. The structure-activity relationship of the vanadium complexes in inhibiting protein tyrosine phosphatases (protein tyrosine phosphatase 1B, PTP1B; T-cell protein tyrosine phosphatase, TCPTP; megakaryocyte protein-tyrosine phosphatase, PTP-MEG2; Src homology phosphatase 1, SHP-1 and Src homology phosphatase 2, SHP-2) was investigated. The oxovanadium(IV) complexes were potent inhibitors of PTP1B, TCPTP, PTP-MEG2, SHP-1 and SHP-2, but exhibited different inhibitory abilities over different PTPs. Complexes 2 and 4 displayed better selectivity to PTP1B over the other four PTPs. Kinetic data showed that complex 2 inhibited PTP1B, TCPTP and SHP-1 with a noncompetitive inhibition mode, but a classical competitive inhibition mode for PTP-MEG2 and SHP-2. The results demonstrated that both the structures of vanadium complexes and the conformations of PTPs influenced PTP inhibition activity. The proper modification of the organic ligand moieties may result in screening potent and selective vanadium-based PTP1B inhibitors.

Inhibitory Activities of Some Oxovanadium Complexes with N-Heterocyclic Ligands against PTP1B/ALP

PTPs inhibition by some oxovanadium complexes with bioligands

Exploration of Biguanido–oxovanadium Complexes As Potent and Selective Inhibitors of Protein Tyrosine Phosphatases

Synthesis and Evaluation of Oxovanadium(Iv) Complexes of Schiff-Base Condensates from 5-Substituted-2-hydroxybenzaldehyde and 2-Substituted-benzenamine As Selective Inhibitors of Protein Tyrosine Phosphatase 1B

Ternary Oxovanadium(Iv) Complexes with Amino Acid-Schiff Base and Polypyridyl Derivatives: Synthesis, Characterization, and Protein Tyrosine Phosphatase 1b Inhibition

Ternary Oxovanadium(iv) Complexes of ONO-donor Schiff Base and Polypyridyl Derivatives As Protein Tyrosine Phosphatase Inhibitors: Synthesis, Characterization, and Biological Activities

Inhibition protein tyrosine phosphatases by an oxovanadium glutamate complex, Na 2 [VO(Glu) 2 (CH 3 OH)](Glu = glutamate)

Inhibition protein tyrosine phosphatases by an oxovanadium glutamate complex, Na[VO(Glu)(CHOH)](Glu = glutamate)

Inhibition Effects of Some Bioactive Peroxovanadium Complexes on the Tyrosine Phosphatase.

A Dioxidovanadium (V) Complex of NNO-donor Schiff Base As a Selective Inhibitor of Protein Tyrosine Phosphatase 1B: Synthesis, Characterization, and Biological Activities

Synthesis, Characterization and PTP1B Inhibitory Activity of the Vanadium Complexes with Amino-acids

Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances

A Novel PTP1b Inhibitor Vanadium-Flavone Complex: Synthesis and Pharmacodynamic Evaluation in Streptozotocin-Induced Diabetic Mice

Synthesis and Characterization of Oxidovanadium Complexes As Enzyme Inhibitors Targeting Dipeptidyl Peptidase IV.

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Convergent Protein Phosphatase Inhibitor Design for PTP1B and TCPTP: Exchangeable Vanadium Coordination Complexes on Graphene Quantum Dots

Studies on the Interactions Between Bioactive Peroxovanadium Complexes Bearing Organic Ligands and Histidine

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

Discovery of Core-Structurally Novel PTP1B Inhibitors with Specific Selectivity Containing Oxindole-Fused Spirotetrahydrofurochroman by One-Pot Reaction.

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Oxovanadium Phenanthroimidazole Derivatives: Synthesis, DNA Binding and Antitumor Activities